Stallergenes Greer

#DidYouKnow that due to cross-reactivity, individuals who are allergic to certain substances may develop allergic reactions to less common allergy provoking substances. Cross-reactivity occurs when the immune system recognises similar protein structures in allergens from different sources. For example, people who are allergic to birch pollen may also have an allergic reaction when eating apples, people who are allergic to ragweed may also react to melon, and those with latex allergy may also react to bananas. Understanding cross-reactivity is crucial for managing allergies, as it helps patients identify potential triggers that might not be immediately obvious. Cross-reactivity can be misleading, especially with food allergies, as it may cause unexpected reactions to foods that are otherwise considered safe. Symptoms of cross-reactivity can vary but often include itching or swelling of the mouth, lips, and throat, digestive discomfort, skin reactions, or even more severe symptoms in some cases. If you experience unusual reactions to foods or other substances, consult your healthcare provider for advice and testing to better manage your allergies. #AllergyWeTakeItPersonally #PrecisionMedicine #Allergy #AllergenImmunotherapy

Discover Dr. Dorra Gharbi, the winner of our Environmental award! Supporting forwards-thinking researchers like Dr. Gharbi is at the heart if how we strive with the Stallergenes Greer Foundation to care beyond allergy, helping to create healthier, more sustainable urban spaces. Watch the video to learn more about her impactful work! #EnvironmentalAward #CareBeyondAllergy #aerobiology #PublicHealth #StallergenesGreerFoundation

Managing #FoodAllergies is a harrowing experience. For people with food allergies, avoidance of food responsible for bothersome symptoms is the first step in preventing an allergic reaction. However, full avoidance is very complex to practice in everyday life as allergens can be hidden everywhere. As accidental exposure is constantly lurking, patients and their family must constantly be on guard. Furthermore, products such as medications or even cosmetics may also contain ingredients which are normally expected to be found only in foods. Due to inconsistencies in labelling, cross-contamination, or environmental exposure, etc. people with food allergies can experience an allergic reaction in the presence of even trace amounts of an allergen such as peanut, shellfish. For example, despite their best efforts in avoiding the food they are allergic to, 1 in 10 individuals is accidentally exposed to peanut allergens¹. Just half a kernel of peanut can trigger a severe allergic reaction²,³ – a reaction which can sometimes be fatal. At Stallergenes Greer, we understand these challenges and we are committed to advancing food #AllergenImmunotherapy for the benefit of patients and the medical community.  #AllergyAwareness #FoodAllergy #Innovation #AllergyWeTakeItPersonally 1. Lange L, et al. Allergo J Int. 2021;30:261-269. 2. Deschildre A, et al. Clin Exp Allergy. 2016;46:610-620. 3. Vickery BP, et al. J Allergy Clin Immunol Pract. 2021;9:1879-1889.e14 2020;4:728-739.

As we transition through the late summer months, countries like France and Germany are witnessing a significant surge in ragweed pollen levels, a situation that has become increasingly problematic. Ragweed, known for its highly allergenic pollen, poses a serious health concern, particularly for those suffering from respiratory conditions like asthma or allergic rhinitis. This increase in ragweed pollen can be attributed to various factors, including climate change and changes in land use, which favor the spread of this invasive species. It is critical to stay informed and take proactive steps to mitigate the impact of ragweed pollen. Whether through promoting awareness, supporting research, or encouraging local initiatives to manage this invasive plant, we all have a role to play. Stallergenes Greer is proud to contribute to this effort by developing innovative allergen immunotherapy treatments. Our commitment is to help those affected by ragweed pollen allergies improve their lives and address this growing environmental and public health challenge. #EnvironmentalHealth #Ragweed #Pollen #ClimateChange #Allergies

Thanks to the support of the #StallergenesGreerFoundation, Associate Professor Rachel Peters' groundbreaking research is shedding light on the long-term impact of food allergies on children's respiratory health. Her findings are crucial for improving patient care and guiding clinicians worldwide. We are proud to support innovation that enhances the well-being of children and helps shape the future of allergy treatment. Learn more about A/Prof Rachel Peters' research!

"I am proud to be part of the team that provides software support and solutions to assist manufacturing in their goals for process improvement and innovation,” Lacey McCaw, Business Intelligence Software Analyst. Lacey works at Stallergenes Greer’s Lenoir (NC) site. She is responsible for gathering business data and studying industry trends to analyze company performance and look for areas of improvement. Every day, Stallergenes Greer colleagues across the globe work together to deliver safe, efficient, and high-quality allergen immunotherapy treatments to improve the quality of life of patients like Will who suffer from respiratory, food or insect venom allergy. #AllergenImmunotherapy #AllergyWeTakeItPersonally #RespiratoryAllergy #FoodAllergy #InsectVenomAllergy

Stallergenes Greer today announced that the U.S. Food and Drug Administration (FDA) has approved Palforzia® [Peanut (Arachis hypogaea) Allergen Powder-dnfp], for the treatment of toddlers (ages 1-3 years) with a confirmed diagnosis of a peanut allergy. This approval expands the January 2020 FDA approval for patients ages 4-17 years. Palforzia® is to date the first and only approved oral immunotherapy treatment (OIT) for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut. “We are delighted that Palforzia® has received regulatory approval in the U.S. for toddlers as there is a high unmet medical need for this age group and we are confident that this indication extension will alleviate the burden of peanut allergy for younger patients and their families,” says Elena Rizova, MD, PHD, Chief Medical Officer of Stallergenes Greer. The FDA approval in toddlers is based on data from the Phase 3 POSEIDON (Peanut Oral Immunotherapy Study of Early Intervention for Desensitization) study that was published in the New England Journal of Medicine Evidence in 2023. The study evaluated the efficacy and safety of Palforzia® in peanut-allergic children aged 1 to 3 years old, meeting all its primary and secondary efficacy endpoints and demonstrating a favourable safety profile.   Read the full press release here: https://lnkd.in/ex4R8efp

𝗦𝘁𝗮𝗹𝗹𝗲𝗿𝗴𝗲𝗻𝗲𝘀 𝗚𝗿𝗲𝗲𝗿 𝗶𝘀 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘀𝗽𝗼𝗻𝘀𝗼𝗿 𝘁𝗵𝗲 𝟮𝟬𝟮𝟰 𝗔𝗹𝗹𝗲𝗿𝗴𝗲𝗻 𝗪𝗮𝗹𝗸𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆! Join us for a unique opportunity to deepen your understanding of allergenic pollens in the environment. 🌿 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗮𝗻 𝗔𝗹𝗹𝗲𝗿𝗴𝗲𝗻 𝗪𝗮𝗹𝗸?  An allergen walk introduces participants to the plants that may contribute to their patients’ allergic conditions. Our knowledgeable scientist and botany specialist, Bob Jacobson*, will guide us through the area around the convention center, identifying plants that produce allergenic pollens and explaining their significance in atopic dermatitis. 🌿 𝗞𝗲𝘆 𝗣𝗼𝗶𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱: • Pollen production and characteristics • Male and female flowers and their relationship to allergenicity • Seasonality of pollen production by different species • Cross-reactivity of allergens from different species • How pollen is collected and processed into sterile products for testing and treatment • Other allergen sources such as fungi and insects By participating, you’ll gain valuable insights to help you better explain the role of plants and other species in your patients’ allergic signs, helping to educate your pet owners about the pollens that may be affecting their beloved pets. We will embark on our adventures Saturday at 12:15pm-1:15pm and Sunday 6:45am-7:45am, rain or shine. We encourage you to come in comfortable shoes for walking and bring along your camera to take photos of the different species we will encounter along the way! 🌿 𝗔𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 #𝗪𝗖𝗩𝗗𝟭𝟬 𝗮𝗻𝗱 𝘄𝗮𝗻𝘁 𝘁𝗼 𝗮𝘁𝘁𝗲𝗻𝗱 𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗯𝗼𝘁𝗮𝗻𝗶𝗰𝗮𝗹 𝗮𝗱𝘃𝗲𝗻𝘁𝘂𝗿𝗲𝘀? Email Sherry Brown at sherry.brown@stallergenesgreer.com and specify which day/time you prefer. 𝗛𝘂𝗿𝗿𝘆! 𝗦𝗽𝗮𝗰𝗲 𝗶𝘀 𝗹𝗶𝗺𝗶𝘁𝗲𝗱! *𝘉𝘰𝘣 𝘑𝘢𝘤𝘰𝘣𝘴𝘰𝘯 𝘪𝘴 𝘣𝘦𝘪𝘯𝘨 𝘤𝘰𝘮𝘱𝘦𝘯𝘴𝘢𝘵𝘦𝘥 𝘣𝘺 𝘚𝘵𝘢𝘭𝘭𝘦𝘳𝘨𝘦𝘯𝘦𝘴 𝘎𝘳𝘦𝘦𝘳 #StallergenesGreer #PetsGetAllergies #WCVD2024 #WCVD10 #AllergenWalks #VeterinaryDermatology #AnimalHealth #Botany #Pollen #Fungi #Insects

𝗦𝘁𝗮𝗹𝗹𝗲𝗿𝗴𝗲𝗻𝗲𝘀 𝗚𝗿𝗲𝗲𝗿 𝗶𝘀 𝗲𝘅𝗰𝗶𝘁𝗲𝗱 𝘁𝗼 𝘀𝗽𝗼𝗻𝘀𝗼𝗿 𝗮𝗻𝗱 𝗮𝘁𝘁𝗲𝗻𝗱 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝗕𝗼𝘀𝘁𝗼𝗻, 𝗠𝗔! From July 25-29, we will be joining veterinary practitioners, researchers, and industry leaders from around the world to explore the latest advancements in veterinary dermatology. This event is a fantastic opportunity to share knowledge, network with peers, and discover innovative approaches to enhancing animal health and well-being. We look forward to engaging with fellow professionals, attending insightful sessions, and highlighting our latest products and services designed to support veterinary dermatologists in their vital work of helping animals with atopic dermatitis and other skin diseases. 𝗜𝗳 𝘆𝗼𝘂'𝗿𝗲 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗰𝗼𝗻𝗴𝗿𝗲𝘀𝘀, 𝗯𝗲 𝘀𝘂𝗿𝗲 𝘁𝗼 𝘃𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗕𝗼𝗼𝘁𝗵 #𝟮𝟱 – 𝘄𝗲'𝗱 𝗹𝗼𝘃𝗲 𝘁𝗼 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗮𝗻𝗱 𝗲𝗱𝘂𝗰𝗮𝘁𝗲 𝗼𝗻 𝗮𝗹𝗹𝗲𝗿𝗴𝗲𝗻-𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝘄𝗶𝘁𝗵𝗶𝗻 𝘆𝗼𝘂𝗿 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗲.   #StallergenesGreer #PetsGetAllergies #VeterinaryDermatology #WCVD2024 #WCVD10 #Boston #AnimalHealth #Innovation #VeterinaryMedicine #AllergenSpecificImmunotherapy

Follow the Stallergenes Greer Foundation to stay updated on its ongoing efforts to support groundbreaking allergy research and innovations that benefit patients worldwide! https://lnkd.in/ea2Tt6gk